Nephros (NEPH) Operating Margin (2010 - 2026)

Nephros' Operating Margin history runs 17 years deep, the most recent figure standing at 1.86% for Q1 2026.

• On a quarterly basis, Operating Margin fell 974.0% year-over-year to 1.86% in Q1 2026; TTM through Mar 2026 was 3.54%, a 144.0% decrease from a year earlier, with the FY2025 full-year figure at 6.1%, up 606.0% from the prior year.
• Operating Margin rose to 1.86% in Q1 2026 per NEPH's latest filing, from 0.38% in the prior quarter.
• Across five years, Operating Margin topped out at 11.61% in Q1 2025 and bottomed at 71.65% in Q1 2022.
• The 5-year median for Operating Margin is 5.68% (2024), against an average of 11.87%.
• Across the five-year window, Operating Margin tumbled 3445 bps in 2022 and soared 6338 bps in 2023, its largest moves.
• Year by year, Operating Margin stood at 27.09% in 2022, then grew by 26 bps to 19.94% in 2023, then jumped by 141 bps to 8.19% in 2024, then plunged by 95 bps to 0.38% in 2025, then surged by 389 bps to 1.86% in 2026.
• Per Business Quant, the three latest NEPH Operating Margin figures stand at 1.86% (Q1 2026), 0.38% (Q4 2025), and 6.59% (Q3 2025).